$1,000 invested Bristol-Myers Squibb (2016)
NYSE · BMY · reinvest dividends · adjusted close
●Result2016-01-04 — 2026-10-15
Today you would have
$1,285
+$285 (+28.53%)
BMYSPY (benchmark)
- Entry price
- $47.13
- Current price
- $60.57
- Shares
- 21.2196
- CAGR
- +2.36%
- Max Drawdown
- -47.67%
- vs SPY
- -325.71 pp
✦The story
A $1,000 stake in Bristol-Myers Squibb from January 2016 grew to just $1,285 by mid-2026, a total return of +28.5%. Despite major moves such as the acquisition of Celgene in 2019, the stock delivered only modest gains over the decade. The S&P 500 returned +354.2% over the same period.
#Related scenariosfor comparison
Other years for BMY